Accessibility Menu

Here's Why Invitae Lost 15.2% in October

The fast-growing leader in genetic testing soared past a $1 billion market cap in September. Investors reconsidered prior to the release of third-quarter 2018 earnings.

By Maxx Chatsko Updated Nov 7, 2018 at 8:26PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.